Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Journey Medical Corp as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +3 vs. Q1 2023
- Shares held
- 1.65M
- −40.9K (−2.4%) vs. Q1 2023
- Total value
- $2.63M
- +$7.22K (+0.3%) vs. Q1 2023
- New holders
- 5
- 4 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DERM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $75.2M |
| Q1 2026 | 72 | $55.8M |
| Q4 2025 | 77 | $85.0M |
| Q3 2025 | 68 | $61.9M |
| Q2 2025 | 56 | $46.6M |
| Q1 2025 | 38 | $29.6M |
| Q4 2024 | 37 | $14.8M |
| Q3 2024 | 36 | $12.2M |
| Q2 2024 | 35 | $13.3M |
| Q1 2024 | 33 | $6.68M |
| Q4 2023 | 36 | $7.80M |
| Q3 2023 | 21 | $5.85M |
| Q2 2023 | 20 | $2.63M |
| Q1 2023 | 17 | $2.62M |
| Q4 2022 | 18 | $5.13M |
| Q3 2022 | 20 | $4.62M |
| Q2 2022 | 13 | $6.52M |
| Q1 2022 | 14 | $7.94M |
| Q4 2021 | 14 | $8.76M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Journey Medical Corp; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 78 | $0 | 0.00% | +78 | New |
| Wells Fargo & Company | 48 | $76 | 0.00% | +2+4.3% | Added |
| UBS Group AG | 1,875 | $2.98K | 0.00% | −2,323−55.3% | Reduced |
| BerganKDV Wealth Management, LLC | 2,000 | $3.18K | 0.00% | +2,000 | New |
| Tower Research Capital LLC (TRC) | 4,082 | $6.49K | 0.00% | −1,337−24.7% | Reduced |
| Allegiance Financial Group Advisory Services LLC | 10,000 | $15.9K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 11,500 | $18.0K | 0.00% | +11,500 | New |
| Creative Planning | 11,764 | $18.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,016 | $19.1K | 0.00% | +12,016 | New |
| BlackRock Inc. | 15,001 | $23.9K | 0.00% | +6,273+71.9% | Added |
| National Asset Management, Inc. | 17,250 | $27.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 21,033 | $33.4K | 0.00% | +10.0% | Added |
| Brighton Jones LLC | 23,020 | $36.6K | 0.00% | +23,020 | New |
| Geode Capital Management, LLC | 29,494 | $46.9K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 35,294 | $56.1K | 0.00% | 00.0% | Unchanged |
| Neuberger Berman Group LLC | 119,854 | $190.6K | 0.00% | −8,975−7.0% | Reduced |
| Nantahala Capital Management, LLC | 178,706 | $284.1K | 0.03% | −33,651−15.8% | Reduced |
| American Financial Group Inc | 180,000 | $286.0K | 0.09% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 226,395 | $360.0K | 0.31% | +8,000+3.7% | Added |
| B. Riley Financial, Inc. | 753,493 | $1.20M | 0.31% | −21,303−2.7% | Reduced |
| Wealth Alliance Advisory Group, LLC | 0 | $0 | 0.00% | −10,748−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −25,421−100.0% | Sold out |